Technical Considerations for the Validation of Electronic Spreadsheets for Complying with 21 CFR Part 11

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-01-01-2003, Volume 27, Issue 1

Bridging the gap between compliant spreadsheet production and limitations in available technology can be achieved by the use of custom-created electronic solutions.

Related Content:

Regulatory/GMP ComplianceQuality SystemsPharmaceutical Technology-01-01-2003
FDA Reports on Status of Postmarketing Requirements and Postmarketing Commitments
Novartis’ Radioligand Therapy Gains FDA Nod for Pediatric Patients
Navigating an Uncertain Regulatory Environment for mRNA-based Products